Jianzhijia Pharmaceutical Chain Group Co., Ltd. (SHA:605266)
China · Delayed Price · Currency is CNY 15.18
-0.04 (-0.26%)
Sep 16, 2026, 3:00 PM CST
SHA:605266 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 15, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 2,255 | 2,848 | 3,614 | 7,654 | 7,940 | 5,324 | |
Market Cap Growth | -30.25% | -21.21% | -52.78% | -3.61% | 49.15% | -9.61% |
Enterprise Value | 5,492 | 6,536 | 7,009 | 9,792 | 10,142 | 5,254 |
Last Close Price | 15.22 | 17.89 | 20.44 | 42.67 | 43.47 | 31.14 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 15, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 17.38 | 19.22 | 28.21 | 18.47 | 21.21 | 17.71 |
Forward PE | - | 7.06 | 7.76 | 16.53 | 21.41 | 15.69 |
PS Ratio | 0.26 | 0.32 | 0.39 | 0.84 | 1.06 | 1.02 |
PB Ratio | 0.89 | 1.07 | 1.30 | 2.69 | 3.09 | 2.81 |
P/TBV Ratio | 54.82 | 16.80 | 14.13 | 20.92 | 31.57 | 3.67 |
P/FCF Ratio | 2.01 | 2.78 | 14.99 | 10.57 | 19.37 | 14.83 |
P/OCF Ratio | 1.86 | 2.43 | 7.10 | 7.47 | 6.67 | 7.15 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 15, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 0.64 | 0.73 | 0.76 | 1.08 | 1.35 | 1.00 |
EV/EBITDA Ratio | 4.79 | 14.85 | 17.52 | 13.84 | 16.92 | 12.58 |
EV/EBIT Ratio | 15.53 | 17.73 | 21.59 | 15.31 | 18.55 | 13.58 |
EV/FCF Ratio | 4.89 | 6.38 | 29.08 | 13.52 | 24.74 | 14.64 |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 15, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 1.62 | 1.60 | 1.56 | 1.30 | 1.14 | 0.68 |
Debt / EBITDA Ratio | 3.59 | 3.65 | 3.76 | 2.66 | 2.54 | 1.48 |
Debt / FCF Ratio | 3.66 | 4.17 | 18.01 | 5.10 | 7.16 | 3.57 |
Net Debt / Equity Ratio | 1.28 | 1.27 | 1.26 | 0.98 | 0.78 | 0.16 |
Net Debt / EBITDA Ratio | 7.71 | 7.73 | 8.79 | 3.94 | 3.33 | 0.72 |
Net Debt / FCF Ratio | 2.88 | 3.32 | 14.59 | 3.85 | 4.88 | 0.83 |
Asset Turnover | 0.90 | 0.88 | 0.90 | 0.93 | 1.01 | 1.21 |
Inventory Turnover | 2.40 | 2.19 | 2.18 | 2.58 | 2.94 | 3.64 |
Quick Ratio | 0.32 | 0.37 | 0.24 | 0.29 | 0.37 | 0.52 |
Current Ratio | 0.76 | 0.81 | 0.86 | 0.81 | 0.93 | 1.03 |
Return on Equity (ROE) | 5.04% | 5.43% | 4.55% | 15.32% | 16.79% | 16.65% |
Return on Assets (ROA) | 2.31% | 2.26% | 1.97% | 4.08% | 4.60% | 5.57% |
Return on Invested Capital (ROIC) | 3.70% | 4.26% | 4.12% | 9.95% | 13.74% | 27.19% |
Return on Capital Employed (ROCE) | 8.80% | 8.40% | 6.30% | 12.60% | 10.10% | 13.80% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 15, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | 5.74% | 5.20% | 3.55% | 5.42% | 4.71% | 5.64% |
FCF Yield | 49.78% | 36.01% | 6.67% | 9.46% | 5.16% | 6.74% |
Dividend Yield | 8.04% | 7.10% | 5.38% | 2.51% | 2.15% | 2.49% |
Payout Ratio | 204.45% | 163.96% | 188.76% | 49.45% | 41.42% | 41.27% |
Buyback Yield / Dilution | 4.45% | 4.03% | 0.17% | -1.91% | -8.55% | -21.58% |
Total Shareholder Return | 12.49% | 11.13% | 5.55% | 0.60% | -6.40% | -19.09% |